Most recently, a follow-up study examined expression levels of EZH2 in CD4+ T cells, as well as the effects on DNA methylation associated with EZH2 overexpression, in participants with SLE versus healthy controls (34). This evidence concerns the gene CD4 and systemic lupus erythematosus.